An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center ...

Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...

GRAIL, Inc. , a healthcare company whose mission is to detect cancer early when it can be cured, will present additional data from both the NHS-Galleri trial and the PATHFINDER 2 study further ...

Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.

A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types in patients with cancers of unknown primary (CUP), according to research ...

A research team led by The Hong Kong University of Science and Technology (HKUST) has developed a pioneering artificial ...

Oregon Health & Science University researchers have developed a first-of-its-kind method to predict cancer patient survival ...

A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to immunotherapy in patients with metastatic non-small cell lung ...

Using pathology slides, Path-IO looks for these niches and other complex patterns that may be challenging for humans to ...